Duration: 1 or 2 days
Description:
This course covers the basics of clinical research and the differences in GMP requirements between commercial medicinal product and Investigational Medicinal Product.
Who it is suitable for:
This course is most suitable for those directly involved in packaging, labelling and shipping IMP.
Content:
Overview of Drug Development Process and phases of clinical trials
- Clinical Trial Process
- Overview of clinical trial lifecycle and key milestones
- Key people – roles and responsibilities
- Dosage Forms & Comparators (Placebo/Active)
- Clinical Trial Design – cross-over vs parallel group studies and implications for IMP
- Randomisation and Blinding of IMP’s
- Critical Implications and Risk Analysis
Current GMP for IMPs and GCP
- Eudralex Vol 4, Annexe 13
- Manufacturing licenses
- Import Regulations
- Special considerations for manufacturing/packaging of IMPs
- Packaging Designs – Primary & Secondary
- Labelling requirements and reconciliation
- QC/QA checks and sample retention
- Packaging instructions
- Distribution Considerations – Cold Chain & Ambient.
- Roles Responsibilities/QP
- Recalls, returns and destruction
- Relabeling
- Documentation
- Reconciliation
- Accountability
- IMP release requirements
|